Monotherapy for low-risk gestational trophoblastic neoplasia with score 5-6
ObjectiveTo investigate the monotherapy for gestational trophoblastic neoplasia (GTN) patients with FIGO/WHO prognostic score of 5–6.MethodsThe low-risk GTN patients from 2012 to 2019 were enrolled. The study is a retrospective report to analyze the efficacy and safety of single-agent chemotherapy a...
Main Authors: | Li Kemin, Zhang Mengpei, Yin Rutie |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.1035170/full |
Similar Items
-
First-line monodrug chemotherapy in low-risk gestational trophoblastic neoplasia: a network meta-analysis
by: Fang Zhou, et al.
Published: (2024-01-01) -
Gestational trophoblastic neoplasm and women living with HIV and/or AIDS
by: Pieter Barnardt, et al.
Published: (2015-07-01) -
Chemoresistant Gestational Trophoblastic Neoplasia: A Case Report
by: SUDHA CP, et al.
Published: (2014-07-01) -
Exploring the real cause of hemoptysis: A case of pulmonary tumor embolism in a young woman with accompanying pulmonary metastasis of gestational trophoblastic neoplasia
by: Qun Hu, et al.
Published: (2023-04-01) -
"Hysteroscopic ablation of Choriocarcinoma in a patient resistant to chemotherapy "
by: Ghazizadeh S, et al.
Published: (2000-09-01)